Equecabtagene Autoleucel
IASO Biotherapeutics
['multiple myeloma', '$ibb', '$xbi', 'iaso bio', 'innovent']
iaso bio and innovent report updated results for equecabtagene autoleucel, a bcma car-t cell therapy, for multiple myeloma at the 2023 asco annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt